We are thrilled to announce that SpOvum’s recent launch of ARTGPT, our AI-powered platform designed to enhance patient support in Assisted Reproductive Technology (ART), has received extensive media coverage. Multiple outlets, including CXOtoday, Business News This Week, Odisha Biz Newz, and Online Media Cafe, have published our press release, underscoring the innovative impact of ARTGPT in the healthcare sector.
With ARTGPT, we’re redefining patient interaction by offering instant, AI-driven support 24/7, tailored specifically for ART patients. This platform leverages natural language processing to provide relevant, fact-based responses and addresses patient queries in multiple regional languages, including Hindi, Kannada, Tamil, Telugu, Bengali, and more. By simplifying complex medical terminology, ARTGPT empowers patients to make informed decisions, improves accessibility, and reduces the anxiety often associated with fertility treatments.
Dr. Ramnath Babu, Co-Founder & CEO of SpOvum, expressed his excitement about this landmark development, stating that ARTGPT is India’s first AI platform dedicated to providing personalized ART support. With advanced privacy protocols, patients can trust that their information remains secure and confidential.
Looking ahead, SpOvum aims to further integrate ARTGPT into our existing ART dashboard and mobile applications, allowing seamless data synchronization for a holistic patient experience. Future updates will include visual and audio support to enhance accessibility and engagement.
For more details on ARTGPT and its transformative role in ART, you can read our full press release on CXOtoday or explore the articles on Business News This Week, Odisha Biz Newz, and Online Media Cafe.
